As of 2026-05-19, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (23.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -200.5%.
The range of the Relative Valuation is (20.30) - (26.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 18.5x | 16.2x |
| Forward P/E multiples | 12.5x - 19.5x | 16.2x |
| Fair Price | (20.30) - (26.34) | (23.12) |
| Upside | -188.2% - -214.5% | -200.5% |
| Date | P/E |